211 related articles for article (PubMed ID: 15382088)
1. Autoregulation of the N-myc gene is operative in neuroblastoma and involves histone deacetylase 2.
Kim MK; Carroll WL
Cancer; 2004 Nov; 101(9):2106-15. PubMed ID: 15382088
[TBL] [Abstract][Full Text] [Related]
2. Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines.
Sivak LE; Tai KF; Smith RS; Dillon PA; Brodeur GM; Carroll WL
Oncogene; 1997 Oct; 15(16):1937-46. PubMed ID: 9365240
[TBL] [Abstract][Full Text] [Related]
3. HIF-1alpha induces MXI1 by alternate promoter usage in human neuroblastoma cells.
Löfstedt T; Fredlund E; Noguera R; Navarro S; Holmquist-Mengelbier L; Beckman S; Påhlman S; Axelson H
Exp Cell Res; 2009 Jul; 315(11):1924-36. PubMed ID: 19254710
[TBL] [Abstract][Full Text] [Related]
4. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression.
Alland L; Muhle R; Hou H; Potes J; Chin L; Schreiber-Agus N; DePinho RA
Nature; 1997 May; 387(6628):49-55. PubMed ID: 9139821
[TBL] [Abstract][Full Text] [Related]
5. Transforming pathways unleashed by a HDAC2 mutation in human cancer.
Ropero S; Ballestar E; Alaminos M; Arango D; Schwartz S; Esteller M
Oncogene; 2008 Jun; 27(28):4008-12. PubMed ID: 18264134
[TBL] [Abstract][Full Text] [Related]
6. Mxi1-SRalpha: a novel Mxi1 isoform with enhanced transcriptional repression potential.
Dugast-Darzacq C; Pirity M; Blanck JK; Scherl A; Schreiber-Agus N
Oncogene; 2004 Nov; 23(55):8887-99. PubMed ID: 15467743
[TBL] [Abstract][Full Text] [Related]
7. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
Marcotte R; Chen JM; Huard S; Wang E
J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
Li H; Wu X
Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
[TBL] [Abstract][Full Text] [Related]
10. MBP-1 physically associates with histone deacetylase for transcriptional repression.
Ghosh AK; Steele R; Ray RB
Biochem Biophys Res Commun; 1999 Jul; 260(2):405-9. PubMed ID: 10403782
[TBL] [Abstract][Full Text] [Related]
11. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.
Lutz W; Schwab M
Oncogene; 1997 Jul; 15(3):303-15. PubMed ID: 9233765
[TBL] [Abstract][Full Text] [Related]
12. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression.
Wu Y; Zhang X; Salmon M; Zehner ZE
Genes Cells; 2007 Aug; 12(8):905-18. PubMed ID: 17663720
[TBL] [Abstract][Full Text] [Related]
13. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.
El-Khoury V; Breuzard G; Fourré N; Dufer J
Br J Cancer; 2007 Aug; 97(4):562-73. PubMed ID: 17667922
[TBL] [Abstract][Full Text] [Related]
14. Repression by the Mad(Mxi1)-Sin3 complex.
Schreiber-Agus N; DePinho RA
Bioessays; 1998 Oct; 20(10):808-18. PubMed ID: 9819568
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects.
Marshall GM; Gherardi S; Xu N; Neiron Z; Trahair T; Scarlett CJ; Chang DK; Liu PY; Jankowski K; Iraci N; Haber M; Norris MD; Keating J; Sekyere E; Jonquieres G; Stossi F; Katzenellenbogen BS; Biankin AV; Perini G; Liu T
Oncogene; 2010 Nov; 29(44):5957-68. PubMed ID: 20697349
[TBL] [Abstract][Full Text] [Related]
16. An inactivating mutation in HDAC2 leads to dysregulation of apoptosis mediated by APAF1.
Hanigan CL; Van Engeland M; De Bruine AP; Wouters KA; Weijenberg MP; Eshleman JR; Herman JG
Gastroenterology; 2008 Nov; 135(5):1654-1664.e2. PubMed ID: 18834886
[TBL] [Abstract][Full Text] [Related]
17. Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cells.
Wada RK; Seeger RC; Reynolds CP; Alloggiamento T; Yamashiro JM; Ruland C; Black AC; Rosenblatt JD
Oncogene; 1992 Apr; 7(4):711-7. PubMed ID: 1565467
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
19. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
Law AY; Lai KP; Lui WC; Wan HT; Wong CK
Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]